RT Journal Article
T1 Transcatheter Treatment of Mitral Regurgitation
A1 McInerney, Angela
A1 De Agustín Loeches, José Alberto
A1 Fernández Ortiz, Antonio Ignacio
A1 Escaned Barbosa, Javier
A1 Jiménez Quevedo, Pilar
AB Mitral valve disease, and in particular mitral regurgitation, is a common clinical entity. Until recently, surgical repair and replacement were the only therapeutic options available, leaving many patients untreated mostly due to excessive surgical risk. Over the last number of years, huge strides have been made regarding percutaneous, catheter-based solutions for mitral valve disease. Transcatheter repair procedures have most commonly been used, and in recent years there has been exponential growth in the number of devices available for transcatheter mitral valve replacement. Furthermore, the evolution of these devices has resulted in both smaller delivery systems and a shift towards transeptal access, negating the need for surgical incisions. In line with these advancements, and clinical trials demonstrating promising outcomes in carefully selected cases, recent guidelines have strengthened their recommendations for these devices. It is appropriate, therefore, to now review the current transcatheter repair and replacement devices available and the evidence for their use.
PB MDPI
SN 2077-0383
YR 2022
FD 2022-05-22
LK https://hdl.handle.net/20.500.14352/134379
UL https://hdl.handle.net/20.500.14352/134379
LA eng
NO McInerney A, Marroquin-Donday L, Tirado-Conte G, Hennessey B, Espejo C, Pozo E, de Agustín A, Gonzalo N, Salinas P, Núñez-Gil I, Fernández-Ortiz A, Mejía-Rentería H, Macaya F, Escaned J, Nombela-Franco L, Jiménez-Quevedo P. Transcatheter Treatment of Mitral Regurgitation. J Clin Med. 2022 May 22;11(10):2921. doi: 10.3390/jcm11102921
DS Docta Complutense
RD 28 abr 2026